Advances in Adaptive Immune Receptor (AIR) Profiling to Accelerate Drug Target Identification and Validation and Biomarker Discovery

Reliable data on the TCR and BCR repertoire have the potential to exponentially increase our understanding of cancer, infectious disease, autoimmunity, and more. However, the immune repertoire profiling tools available to researchers today are complex, limited, and prohibitively expensive. Cellecta's DriverMap AIR technology, for bulk as well as single-cell samples, is changing that. Learn how this highly sensitive and reproducible technology is enabling novel insights in the lab and speeding up target discovery and validation workflows.